ClinConnect ClinConnect Logo
Search / Trial NCT06016530

Multi-level Molecular Profiling of Stress Exposure Under Standardized Food Intake: A Clinical Study

Launched by DR. NILS GASSEN · Aug 24, 2023

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Stress Related Disorders Nutrition Metabolism

ClinConnect Summary

This clinical trial is studying how stress and nutrition affect our bodies over time. Researchers want to understand how what we eat interacts with stress, especially focusing on blood samples from healthy volunteers who will follow a specific diet. To create a stress response, participants will experience sleep deprivation for more than 36 hours. The study will also consider how hormonal changes related to the menstrual cycle might influence the results for female participants.

If you’re between the ages of 18 and 62, healthy, and have a body mass index (BMI) between 18 and 30, you might be eligible to participate. However, individuals with certain conditions, such as those who smoke, have a history of drug or alcohol abuse, or take regular medications (except for specific ones), will not be able to join. Participants can expect to provide blood samples during the study to help researchers learn more about how nutrition and stress impact our overall health. Understanding these connections may lead to better ways to prevent and treat various health issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Present written declaration of consent
  • Healthy
  • BMI between 18 and 30
  • Exclusion Criteria:
  • Insufficient linguistic communication
  • Drug abuse or alcohol dependency
  • Smoker
  • Hormonal contraception
  • Neurological condition or epilepsy in the medical history
  • Regular medication except for L-thyroxine or antihistamines
  • A known disease of the cardiovascular system, hypertension higher than 160/90mmHg

About Dr. Nils Gassen

Dr. Nils Gassen is an esteemed clinical trial sponsor dedicated to advancing medical research and therapeutic innovations. With a robust background in clinical pharmacology and a commitment to patient-centered approaches, Dr. Gassen leads initiatives that prioritize safety, efficacy, and ethical standards in clinical trials. His expertise encompasses a wide range of therapeutic areas, fostering collaborations that drive scientific discovery and improve healthcare outcomes. Through rigorous trial design and implementation, Dr. Gassen aims to contribute significantly to the development of novel treatments and enhance the understanding of complex diseases.

Locations

Bonn, North Rhine Westphalia, Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported